Ultima-Ultrazompic 2 mg

Ultrazompic 2mg/pen by Ultima Pharmaceuticals – GLP-1 Receptor Agonist for Weight Loss

Ultrazompic 2mg/pen by Ultima Pharmaceuticals features Semaglutide, a clinically-backed GLP-1 receptor agonist (GLP-1 RA) used to promote appetite suppression, enhance insulin sensitivity, and facilitate sustainable fat loss. Delivered in a convenient pre-filled pen, this weekly injection supports long-term weight management without harsh stimulants.

Used in 8–16+ week weight loss cycles, Ultrazompic helps reduce food cravings, improve glucose control, and support steady body recomposition.

Often stacked with MK-677, Tirzepatide, or cardio-based SARMs like GW-501516 for complete metabolic optimization.

Men's & Women's dosage:

Start at 0.25mg/week, gradually increase to 1–2mg/week depending on goal and tolerance (subcutaneous, pre-measured pen)

Ultrazompic 2mg is ideal for individuals looking to achieve fat loss, stabilize appetite, and optimize metabolic function with a trusted, easy-to-use solution.